News for AngioDynamics, Inc. (ANGO)

Fourth Quarter Highlights”  Reported revenue of $355.2 million, up 9.4%Constant currency revenue* and constant currency revenue, organic* up 10.1% and u

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

This is our list of the best health care stocks based on the highest return over the last 30 days.

Shares of AngioDynamics Inc (ANGO) fell 6.10% in mid-day trading on Jan 31. The stock reached an intraday low of $11.05, before recovering slightly to $11.70,

AngioDynamics' fiscal Q2'25 results exceeded expectations, with Med Tech growing 25% and delivering better gross margins. See why I rate ANGO stock a buy.

ANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business.

Total Worldwide Revenue: $73 million, growth of approximately 9% year-over-year.MedTech Segment Revenue: $31.6 million, a 25% year-over-year increase.Mechanica

Jan 08, 2025 / 01:00PM GMTOperator Good morning and welcome to the AngioDynamics fiscal year 2025 second quarter earnings call at this time. (Operator instructi

AngioDynamics' NanoKnife FDA clearance boosts its potential in cancer treatment. Read why ANGO stock is a buy with its growth trajectory.

U.S. stocks traded slightly lower midway through trading, with the Dow Jones index falling around 0.1% on Wednesday. The Dow traded down 0.05% to 42,507.21 whi...

AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief Executive...

U.S. stocks were lower, with the Dow Jones index falling over 150 points on Wednesday. Shares of AAR Corp. AIR rose sharply during Tuesday's session after post...

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Tuesday. Shares of Limoneira Company LMNR fell sharply in today's pre-m...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Embolic Protection...

Insider Activity Roundup: Thursday's Top Buys and Sells in US Stocks

U.S. stocks were mostly lower, with the Dow Jones index falling around 300 points on Thursday. Shares of AngioDynamics, Inc. ANGO fell sharply during Thursday'...

U.S. markets closed mixed on Friday, with all three major indices recording gains for the third consecutive week. Data from the Federal Reserve's preferred infl

Loading... Loading... Shares of The Charles Schwab Corporation SCHW fell sharply during Tuesday's session following second-quarter results. Charles Schwab sai...

Innovations in urinary catheter designs such as hydrophilic coatings and antimicrobial agents enhancing patient comfort and driving product sales, says...